Skip to main content

Halogenated Benzamides as Ligands for Cerebral Dopamine Receptors

  • Chapter
Chemists’ Views of Imaging Centers

Abstract

In the past several years our group has synthesized a series of high affinity iodine-123 and fluorine-18 labeled substituted benzamide ligands for SPECT and PET visualization of the dopamine D-2 receptors in brain regions with low receptor density outside the striatum. Radioiodination and radiofluorination in high yield and high specific activity was achieved by using the tributyltin precursor and nucleophilic displacement of the toluensulfonyl ester precursor, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kiesewetter, D.O.; Brucke, T.; Finn, R.D. Radiochemical Synthesis of [18F] Fluororaclopride. Appl. Radiat. Isot. 1989, 40,455–460.

    Article  CAS  Google Scholar 

  2. Fukumura, T.; Dohmoto, H.; Maeda, M.; Fukuzawa, E.; Kojima, M. Synthesis and in vitro Affinity for Dopamine D-2 Receptor of N-Fluorine-Substituted Analogs of Eticlopride. Chem.. Pharm. Bull. 1990, 38, 1740–1742.

    Article  PubMed  CAS  Google Scholar 

  3. Mukherjee, J., Luh, K. E.; Yasillo, N.; Perry B.D.; Levy, D.; Chen, C-T.; Ortega, C., Beck, R. N.; Cooper, M. Dopamine D-2 Receptors Imaged by PET in Cebus apella Using [18F] Benzamide Neuroleptic. Eur J. Pharm. 1990, 175, 363–364.

    Article  CAS  Google Scholar 

  4. Mukherjee, J.; Perry, B.D.; Cooper, M. Fluorinated Benzamide Neuroleptics. J Labelled Cmpnds.and Radiopharm. 1990, 28, 609–616.

    Article  CAS  Google Scholar 

  5. Kiesewetter, D.O.; Kawai, R.; Chelliah M.; Owens, E.; McLellan, C; Blasberg, R.G. Preparation and Biological Evaluation of 18F-labeled Benzamide Analogs as Potential Dopamine D2 Receptor Ligands. Int. J. Radiat. Appl. Instrum. 1990, 17, 347–356.

    Article  CAS  Google Scholar 

  6. Gerdes, J. M.; Bishop, J. E.; Mathis, C. A. Fluoroalkybenzenes: Synthesis of (S)-2.3-Dimethoxy-5-[(3-fluoro)propyl]-6-hydroxy-N-[(l-ethyl-2-pyrrolidinyl) methyl] benzamide. J. Fluorine Chem. 1991, 51, 149–152.

    Article  CAS  Google Scholar 

  7. Hall, H.; Hogberg, T.; Halldin, C; Bengtsson, S.; Wedel, I. Synthesis and Binding Properties of the Fluorinated Substituted Benzamide [3H]NCQ 115, a New Selective Dopamine D2 Receptor Ligand. Eur. J. Pharmacol. 1991, 201, 1–10.

    Article  PubMed  CAS  Google Scholar 

  8. Halldin, C.; Farde L.; Hogberg, T.; Hall, H.; Strom, P.; Ohlberger, A.; Solin, O. A Comparative PET-Study of Five Carbon-11 or Fluorine-18 Labelled Salicylamides. Preparation and In Vitro Dopamine D-2 Receptor Binding. Nucl. Med. Biol. 1991, 18,871–881.

    CAS  Google Scholar 

  9. Mukherjee, J. Fluorinated Benzamide Neuroleptics—2. Synthesis and Radiosynthesis of (S)-N-[(l-ethyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-3-substituted- 2-methoxy- benzamides. Appl. Radiat. Isot. 1991, 42, 713–721.

    Article  CAS  Google Scholar 

  10. Mukherjee, J. Fluorinated Benzamide Neuroleptics—2. Synthesis and Radiosynthesis of (S)-N-[(l-ethyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-3-substituted- 2-methoxy- benzamides. Appl. Radiat. Isot. 1991, 42, 713–721f.

    Article  CAS  Google Scholar 

  11. Watanabe, K.; Fukumura, T.; Sasaki, S.; Maeda, M.; Takehara S. New Fluorine- Substituted Analogue of Eticlopride with High Affinity Toward Dopamine D2 Receptors. Chem. Pharm. Bull. 1991, 39, 3211–3214.

    Article  PubMed  CAS  Google Scholar 

  12. Mathis, C. A.; Bishop, J. E., Gerdes, J. M.; Whitney, J.M., Brennam, K.M., and Jagust, W.J.. Synthesis and Evaluation of High Affinity, Aryl-substituted [18F]Fluoropropylbenzamides for Dopamine D-2 Receptor Studies. Nucl. Med. Biol. 1992, 19,571–588.

    CAS  Google Scholar 

  13. 13. Chumpradit, S.; Kung, M.P.; Billings, J.; Mach R.; Kung. H.F. Fluorinated and Iodinated Dopamine Agents: D2 Imaging Agents for PET and SPECT. J. Med. Chem. 1992.

    Google Scholar 

  14. Sasaki, S.; Takao, F.; Watanabe, K.; Obana, N.; Maeda, M.; Fukumura, T.; Takehara, S. New Fluorinated Dopamine D2 Ligands with Benzofuran Skeleton. The Synthesis and in Vitro Evaluation. Chem. Pharm. Bull. 1993, 41, 296–300.

    Article  PubMed  CAS  Google Scholar 

  15. Kessler, R. M.; Votaw, J. R.; Schmidt, D.E.; Ansari, M.S.; Holdeman, K.P.; de Paulis, T.; Clanton, J.A.; Pfeffer, R.; Manning, R.G.; Ebert, M.H. High Affinity Dopamine D2 Receptor Radioligands. 3. [123I] and [125I]Epidepride: In Vivo Studies in Rhesus Monkey Brain and Comparison with In Vitro Pharmacokinetics in Rat Brain. Life Sciences 1993,53,241–250.

    Article  PubMed  CAS  Google Scholar 

  16. Kung, H. F.; Kasliwal, R.; Pan, S.; Kung M-P.; Mach, R. H.; Guo, Y-Z. Dopamine D-2 Receptor Imaging Radiopharmaceuticals: Synthesis, Radiolabeling, and in Vitro Binding of (R)-(+)-and (S)-(-)-3-Iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2- pyrrolidinyl)methyl] benzamide. J. Med. Chem. 1988, 31, 1039–1043.

    Article  PubMed  CAS  Google Scholar 

  17. de Paulis, T.; Janowsky, A.; Kessler, R.M.; Clanton, J.A.; Smith H.E. (S)-N-[(l- Ethyl- 2-pyrrolidinyl)methyl]-5-[125I]iodo-2-methoxybenzamide Hydrochloride, a New Selective Radioligand for Dopamine D-2 Receptors. J. Med. Chem. 1988, 31,2027–2033.

    Article  PubMed  CAS  Google Scholar 

  18. Kung, H.F.; Pan, S.; Kung, M-P.; Billings, J.; Kasliwal, R.; Reilley, J.; Alavi, A. In Vitro and In Vivo Evaluation of [123I]IBZM: A Potential CNS D-2 Dopamine Receptor Imaging Agent. J. Nucl. Med. 1989, 30, 88–92.

    PubMed  CAS  Google Scholar 

  19. Sanchez-Roa, P.M.; Grigoriadis, D.E.; Wilson, A.A.; Sharkey, J.; Dannais, R.F.; Villemagne, V.L.; Wong, D.F.; Wagner, H.N. Kuhar, M.J.; [125]I-Spectramide: A Novel Benzamide Displaying Potent and Selective Effects at the D2 Dopamine Receptor. Life Sci. 1989,45,1821–1829.

    Article  PubMed  CAS  Google Scholar 

  20. Hogberg, T.; Strom, P.; Hall, H.; Kohler, G; Halldin, G; Farde, L. Syntheses of [123I]-, [125T]- and Unlabelled (S)-3-iodo-5,6-dimethoxy-N-[l-ethyl-2- pyrrolidinyl) methyl] salicylamide (NCQ 298), Selective Ligands for the Study of Dopamine D-2 Receptors. Acta. Pharm. Nord. 1990, 1, 53–60.

    Google Scholar 

  21. Murphy, R.A.; Kung, H.F.; Kung, M-P.; Billings, J. Synthesis and Characterization of Iodobenzamide Analogues: Potential D-2 Dopamine Receptor Imaging Agents. J. Med. Chem. 1990, 33, 171–178.

    Article  PubMed  CAS  Google Scholar 

  22. Hogberg, T de Paulis, T.; Johansson, L.; Kumar, Y.; Hall, H.; Ogren, S.O..; Potential Antipsychotic Agents. 7. Synthesis and Antidopamingergic Properties of the Atypical Highly Potent (S)-5-Bromo-2,3-dimethoxy-N-[(l-ethyl-2-pyrrolidinyl) methyl]benzamide and Related Compounds. A Comparative Study. J. Med. Chem. 1990, 33, 2305–2309.

    Article  PubMed  CAS  Google Scholar 

  23. Kessler, R.M.; Ansari, M.S de Paulis, T.; Schmidt, D.E.; Clanton Smith, H.E.; Manning, R.G.; Gillespie, D.; Ebert, M.H..; High Affinity Dopamine D2 Receptor Radioligands. 1. Regional Rat Brain Distribution of Iodinated Benzamides. J. Nucl. Med. 1991, 32, 1593–1600.

    PubMed  CAS  Google Scholar 

  24. Clanton, J.A de Paulis, T., Schmidt, D.E., Ansari, M.S.; Manning, R.G.; Baldwin, R.M.; Kessler, R.M..; Preparation of [123I]- and [125I]Epidepride: A Dopamine D-2 Receptor Antagonist Radioligand. J. Label Cmpnd Radiopharma 1991, 29, 745–751.

    Article  CAS  Google Scholar 

  25. de Paulis, T.; Bingham, D.R.; Manning, R.G.; Mason, N.S.; Ansari, M.S.; Schmidt, D.E.; Kessler, R. M. Design and Radiogluorination of Benzamide Dopamine D2 Receptor Ligands. New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control 1991, 97–107.

    Google Scholar 

  26. Kessler, R.M.; Ansari, M.S.; Schmidt de Paulis, T.; Clanton, J.A.; Innis, R.; Al- Tikriti, M.; Manning, R.G.; Gillespie, D., D.E.; High Affinity Dopamine D2 Receptor Radioligands. 2. [125I] Epidepride, a Potent and Specific Radioligand for the Characterization of Striatal and Extrastriatal Dopamine D2 Receptors. Life Sci 1991, 49, 617–628.

    Article  PubMed  CAS  Google Scholar 

  27. Kessler, R.M.; Whetsell, W.O.; Ansari, M.S.; Votaw, J.R de Paulis, T.; Clanton, J.A.; Schmidt, D.E.; Mason, N.S.; Manning, R.G..; Identification of Extrastriatal Dopamine D2 Receptors in Post Mortem Human Brain with [125I]Epidepride. Brain Res. 1993, 609, 237–243.

    Article  PubMed  CAS  Google Scholar 

  28. Kessler, R.M.; Mason, N.S.; Votaw, J.R de Paulis, T.; Clanton, J.A.; Ansari, M.S.; Schmidt, D.E.; Manning, R.G.; Bell, R.L..; Visualization of Extrastriatal Dopamine D-2 Receptors in the Human Brain. Eur. J. Pharmacol. 1992, 223, 105–107.

    Article  PubMed  CAS  Google Scholar 

  29. Kessler, R.M.; Votaw, J.R de Paulis, T.; Bingham, D.R.; Ansari, M.S.; Mason, N.S.; Holburn, G.; Schmidt, D.E.; Votaw, D.B.; Manning, R.G.; Ebert, M.H..; Evaluation of 5-[18F]Fluoropropylepidepride as a Potential PET Radioligand for Imaging Dopamine D2 Receptors. Synapse 1993,15,169–176.

    Article  PubMed  CAS  Google Scholar 

  30. Neve, K.A.; Henningsen, R.A.; Kinzie, J.M de Paulis, T.; Schmidt, D.E.; Kessler, R.M.; Janowsky, A..; Sodium-Dependent Isomerization of Dopamine D-2 Receptors Characterized Using [125I]Epidepride, a High-Affinity Substituted Benzamide Ligand. J. Pharmacol. Exp. Ther. 1990, 252, 1108–1116.

    PubMed  CAS  Google Scholar 

  31. Kung, H.F.; Alavi, A.; Chang, W.; Kung, M-P.; Keyes, J.W.; Velchik, M.G.; Billings, J.; Pan, S.; Noto, R.; Rausch, A.; Reilley, J. In Vivo SPECT Imaging of CNS D-2 Dopamine Receptors: Initial Studies with Iodine- 123-IBZM in Humans. J. Nucl. Med. 1990,31,573–579.

    PubMed  CAS  Google Scholar 

  32. Kung, M-P.; Kung, H.F.; Billings, J.; Yang, Y.; Murphy, R.; Alavi, A. The Characterization of IBF as a New Selective Dopamine D-2 Receptor Imaging Agent. J. Nucl. Med. 1990, 31,648–654.

    PubMed  CAS  Google Scholar 

  33. Brucke, T.; Podreka, I.; Angelberger, P.; Wenger, S.; Topitz, A.; Kufferle, B.; Müller, C; Deecke, L. Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders. J. Cereb. Blood Flow Metab 1991, 11, 220–228.

    Article  PubMed  CAS  Google Scholar 

  34. Verhoeff, N.P.L.G.; Bobeldijk, M.; Feenstra, M.G.P.; Boer, G.J.; Maas, M.A.W.; Erdtsieck-Ernste, E.; De Bruin, K. Van Royen, E.A.; In Vitro and In Vivo D2- Dopamine Receptor Binding with [123I]S(-)iodobenzamide ([123I]IBZM) in Rat and Human Brain. Nucl. Bed. Biol. 1991, 18, 837–846.

    CAS  Google Scholar 

  35. Joyce, J. N.; Janowsky, A.; Neve, K.A. Characterization and Distribution of [125I]Epidepride Binding to Dopamine D2 Receptors in Basal Ganglia and Cortex of Human Brain. J. Pharmacol. Exp. Ther. 1991, 257, 1253–1263.

    PubMed  CAS  Google Scholar 

  36. Innis, R.B.; Malison, R.T.; Al-Tikriti, M.; Hoffer, P.B.; Sybirska, E.H.; Seibyl, J.P.; Zoghbi, S.S.; Baldwin, R.M.; Laruelle, M.; Smith, E.O.; Charney, D.S.; Heninger, G.; Elsworth, J.D.; Roth, R.H. Amphetamine-Stimulated Dopamine Release Competes In Vivo for [123I]ibzM Binding to the D2 Receptor in Nonhuman Primates. Synapse 1992, 10, 177–184.

    Article  PubMed  CAS  Google Scholar 

  37. Hall, H.; Hogberg, T; Halldin, C; Kohler, C; Strom, P.; Ross, S.B.; Larsson, S.A.; Farde, L. NCQ 298, A New Selective iodinated Salicylamide Ligand for the Labelling of Dopamine-D2 Receptors. Psychopharm. 1991, 103,6.

    Article  CAS  Google Scholar 

  38. Votaw, J.R.; Kessler, R.M de Paulis, T.; Ansari, M.S.; Mason, N.S.; Schmidt, D.E., Manning, R.G.; Holburn, G..; Quantification of Striatal and Extra-Striatal Dopamine D2 Receptors Using N-Allyl Fluoropropylepidepride. J. Nucl. Med. 1993, 34, 132 (abst.).

    Google Scholar 

  39. Baldwin, R.M.; Al-Tikriti, M.S.; Zea-Ponce, Y.; Zoghbi, S.S.; Sybirska, E.H.; Malison, R.T.; Laruelle, M.; Kung, H.F.; Kessler, R.M de Paulis, T.; Nakatsuka, I.; Saji, H.; Smith, E.O.; Wisniewski, G.; Charney, D.S.; Hoffer, P.B.; Innis, R.B..; In Vivo Comparison of 3 Radioiodinated High Affinity Dopamine D2 Receptor Ligands: IBF, EPID, and 2′-ISP. J. Nucl. Med. 1992, 33, 848 (abst.).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Manning, R.G., Mason, N.S., de Paulis, T., Kessler, R.M. (1995). Halogenated Benzamides as Ligands for Cerebral Dopamine Receptors. In: Emran, A.M. (eds) Chemists’ Views of Imaging Centers. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9670-4_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9670-4_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9672-8

  • Online ISBN: 978-1-4757-9670-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics